-

Mountainside Warns About The Dangers of K-Holes And Why They're Scarier Than You Think

NEW YORK--(BUSINESS WIRE)--There has been a lot of talk lately about ketamine, but many people don’t understand the risks of a “K-hole,” the vernacular for the trance-like state it can produce.

“I have had several clients who started using ketamine for depression and then found that they developed a dependence on the drug,” said Daniel Sexton, Program Manager of Outpatient Services at Mountainside Treatment Center.

Share

Ketamine is a dissociative anesthetic, used for decades in human and veterinary medicine to sedate patients and relieve pain. The Drug Enforcement Administration (DEA) notes that it distorts sight and sound and leaves users feeling disoriented and not in control. At higher recreational doses, the detachment can deepen into what users call a “K-hole,” which the DEA describes as an out-of-body, near-death experience.

The body is present, the world feels remote, and the person may be unable to move or respond. Because ketamine can cause immobility and amnesia, they may later remember little of what happened.

As the body metabolizes ketamine and the dissociative effects wear off, normal sensory processing starts to return. Some people may experience emergence delirium, with symptoms including confusion about where they are or what is real, delusions, paranoia, agitation, or combative behavior.

The risk isn’t only what happens inside a K-hole; it’s what can happen around the person. Someone who is dissociated may be unable to protect themselves, call for help, or leave a bad situation. The DEA has noted that ketamine has been used to facilitate sexual assault.

“I have had several clients who started using ketamine for depression and then found that they developed a dependence on the drug,” said Daniel Sexton, Program Manager of Outpatient Services at Mountainside Treatment Center. “Ketamine offers an alluring escape from their issues, but ultimately those issues compound. Both the user and their loved ones may find themselves trapped in a cycle of use and pain, aware of their situation but unable to break free. A metaphorical K-hole.”

“The out-of-body experience coupled with, in many cases, no recollection or a distorted recollection of the events, leaves users extremely vulnerable,” said Dr. Karen O’Flynn, Medical Director at Mountainside Treatment Center.

Mountainside encourages anyone concerned about their ketamine use or experiencing symptoms of depression to seek support from a qualified healthcare professional.

Daniel Sexton and Dr. Karen O’Flynn are available for expert commentary on the risks of recreational ketamine use, dissociation, and dependence.

About Mountainside Treatment Center

Mountainside Treatment Center is a nationally recognized behavioral health organization specializing in the treatment of substance use disorders and co-occurring mental health conditions. Through evidence-based care, innovative programming, and community partnerships, Mountainside helps build meaningful lives in recovery.

Contacts

Media Contact:
Griffin Gonzales
Director, Media Relations
231-794-9450
griffin.gonzales@mountainside.com

Mountainside Treatment Center


Release Versions

Contacts

Media Contact:
Griffin Gonzales
Director, Media Relations
231-794-9450
griffin.gonzales@mountainside.com

Social Media Profiles
More News From Mountainside Treatment Center

Mountainside Calls Attention to the Veterans We Aren't Reaching

CANAAN, Conn.--(BUSINESS WIRE)--This Veterans Day, Mountainside Treatment Center is calling attention to a critical question in veteran mental healthcare: Who is reaching the veterans who aren't connected to traditional support systems? According to the U.S. Department of Veterans Affairs' 2026 National Veteran Suicide Prevention Annual Report, 62% of veterans who died by suicide in 2024 had not received VA healthcare in the year they died or the preceding year. The finding highlights the impor...

Mountainside Warns of Ketamine Risks at American Colleges and Universities

NEW YORK--(BUSINESS WIRE)--As recent headlines ignite conversations about ketamine use across campuses, Mountainside Treatment Center is urging colleges and universities to ensure students have clear information about the dangers of ketamine and to make support available to the campus community. Ketamine was first synthesized in 1962 and approved by the U.S. FDA in 1970. It is primarily used as an anesthetic in medical settings but has gained attention for its off-label use in treating conditio...

Mountainside Issues Warning on Kratom and Cychlorphine Following Ole Miss Student Deaths

NEW YORK--(BUSINESS WIRE)--Following the deaths of two University of Mississippi students, Mountainside is urging families and college communities to seek reliable information about kratom and cychlorphine, an emerging synthetic opioid. Authorities reported finding retail-packaged kratom during two separate death investigations. They have not determined that kratom or any other substance contributed to either death, established that the deaths are connected, or reported finding cychlorphine in...
Back to Newsroom